Page 96 - Number One

Antibiotice SA the only producer of medicines with the majority shareholding owned by the Romanian State is expanding
to Asian markets
Antibiotice SA SA (Antibiotics SA) Iași one of of the the most important producers of of generic drugs in in the the the pharmaceutical industry and the the the the only company in in in in this field in in in in which the the the Romanian state owns the the the majority stake announced that it it had found business opportunities on on on new markets
such as Saudi Arabia Hong Kong Cambodia and Macao Moreover Antibiotice SA intends to to develop projects in in in Slovenia Croatia and Montenegro according to to the the the half‐yearly report published on on the the the website of the the the Bucharest Stock Exchange (BVB) “The development strategy on the the European market also targets the the the countries of Central and Eastern Europe Europe where starting from the the coordination center in in in in Serbia we will will develop projects in in in in countries such as Slovenia Croatia Montenegro Exports from Russia & C C I S S will will focus in in in in the the the future on on the the the representative office in in in in Ukraine from where we we will coordinate the the the the projects that we we have in in in this region” the the the report shows Currently about 29% of the the company’s production is is exported “Even though in in the the the the recent years in in the the the the Middle East Southeast Asia there has been a a a a a a a a a a strong pressure on on on prices Antibiotice SA managed to to to retain its main traditional customers and to to to identify business opportunities in in new markets
such as Saudi Arabia Hong Kong Cambodia Macao In Romania the company had an an an increase of of gross sales revenues of of of 11 5% from RON 136 8 million million to 152 5 5 5 million million in the the the first six months of of the the the year” the the the company report shows In the first semester of of of 2019 Antibiotice Iași achieved a a a a a a net profit of of of of RON RON 22 31 million million and sales revenues of of of of RON RON 172 39 million million Also the the export levels increased by 6 34% compared to the the similar period of of 2018 94 Number One
Asia the company’s main export market “The main destinations for the the products products of Antibiotice SA (finished products products and Nystatin) in in in in in the the first half of 2019 were: Asia (35%) North America (20%)
and Europe (15%) Sales in these areas accounted
for for about 70% of the the the sales made on foreign markets” the the report shows Antibiotice SA has representative offices in in Vietnam Ukraine Moldova and Serbia “South East Asia is one of of of the the markets
in in in which the the opening of of of a a a a a a a a a a a a representative office in in in Vietnam allowed for accelerated sales sales growth and the implementation of of trade policies adapted to all sales sales channels Sales of of finished products on this market increased Photo Pixabay